Document Detail


Development of diaphragmatic weakness after transcatheter arterial chemoembolization of the right inferior phrenic artery: frequency and determinant factors.
MedLine Citation:
PMID:  19157895     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To assess the frequency of diaphragmatic weakness and its determinant factors after transcatheter arterial chemoembolization of the right inferior phrenic artery (IPA) in patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: From June 2006 to October 2006, 60 patients (48 men, 12 women; mean age, 59 years) who had undergone chemoembolization of the right IPA underwent follow-up angiography of the right IPA and fluoroscopic diaphragmatic movement assessment. Diaphragmatic weakness was determined by the presence of paradoxical or decreased movement at fluoroscopy. As determinant factors, the extent of embolization (selective chemoembolization of the anterior or posterior branch vs nonselective chemoembolization), the use of gelatin sponge pledgets, additional cisplatin infusion, the size of a tumor supplied by the right IPA (>or=48 mm vs <48 mm), multiplicity of right IPA chemoembolization, and the extent of occlusive changes (single vs both branches) at follow-up right IPA angiography were assessed. The chi(2) and logistic regression tests were used to identify determinant factors of diaphragmatic weakness. RESULTS: Diaphragmatic weakness occurred in 11 of the 60 patients (18%). All 11 patients complained of shoulder pain during chemoembolization, but persistent dyspnea did not develop. Nonselective embolization (P = .005) and occlusive changes of both right IPA branches at follow-up angiography (P = .002) were significant determinant factors, as determined with univariate analysis. As determined with multivariate analysis, an occlusive change of both right IPA branches was the only significant determinant factor (P = .009; odds ratio, 17.2). Diaphragmatic weakness developed in 10 of the 28 patients (36%) with occlusive changes of both right IPA branches and only one (3.1%) of the remaining 32 patients. CONCLUSIONS: When chemoembolization of the right IPA is nonselectively performed and with permanent occlusive changes of the right IPA, diaphragmatic weakness can develop in one-third of patients as an ischemic complication.
Authors:
Dong Ho Lee; Jin Wook Chung; Hyo-Cheol Kim; Hwan Jun Jae; Chang Jin Yoon; Sung Gwon Kang; Ung Bae Jeon; Young Ho So; Yong Hu Yin; Jae Hyung Park
Related Documents :
10369235 - Measurement of ischemia by changes in tissue oxygen, carbon dioxide, and ph.
20566075 - Local intra-arterial fibrinolysis in acute basilar artery occlusion.
14504335 - Acute basilar artery occlusion treated by thromboaspiration in a cocaine and ecstasy ab...
18201465 - Digital artery occlusion secondary to plastic shopping bag trauma.
12052585 - Failure of methotrexate and internal iliac balloon catheterization to manage placenta p...
19918515 - Neurofibromatosis type 1 and multiple traumatic cervical arterial injuries: a case report.
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2009-01-21
Journal Detail:
Title:  Journal of vascular and interventional radiology : JVIR     Volume:  20     ISSN:  1535-7732     ISO Abbreviation:  J Vasc Interv Radiol     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-30     Completed Date:  2009-07-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203369     Medline TA:  J Vasc Interv Radiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  484-9     Citation Subset:  IM    
Affiliation:
Department of Radiology, Seoul National University Hospital, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Carcinoma, Hepatocellular / epidemiology,  therapy*
Chemoembolization, Therapeutic / adverse effects,  statistics & numerical data*
Comorbidity
Diaphragm / radiography*
Female
Hepatic Artery / radiography
Humans
Incidence
Korea / epidemiology
Liver Neoplasms / epidemiology,  therapy*
Male
Middle Aged
Muscle Weakness / epidemiology*,  etiology,  radiography*
Risk Assessment / methods
Risk Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fluorescence microscopy and 3D image reconstruction of cytokine initiated disruption of the Parkinso...
Next Document:  Infrapopliteal balloon angioplasty for chronic critical limb ischemia in diabetic patients with urem...